## Note
nid: 1473986036899
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_Hematology, #AK_Step1_v11::#B&B::11_Hematology::01_Hemostasis::02_Platelet_Activation, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::03_Physiology::03_Platelet_Plug_Formation_(Primary_Hemostasis), #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::03_Physiology::03_Platelet_Plug_Formation_(Primary_Hemostasis)::3_Adhesion_Activation, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::03_Physiology::04_Thrombogenesis, #AK_Step1_v11::#NBME::29, #AK_Step1_v11::#OME_banner::Basic_Science::13_Hematology_Oncology::11_Hemostasis, #AK_Step1_v11::#Pathoma::04_Hemostasis::01_Primary_Hemostasis_&_Related_Bleeding_Disorders, #AK_Step1_v11::#Physeo::09_Pharm::17_Hem/Onc_Pharm::ADP_Receptors_Inhibitors, #AK_Step1_v11::#Physeo::11_Pathology::10_HemeOnc_Pathology::01_Primary_Hemostasis, #AK_Step1_v11::^Other::^EXPN::BGedit, #AK_Step1_v11::^Other::^FA_Updates::FA2018, #AK_Step1_v11::^Other::^HighYield::2-RelativelyHighYield, #AK_Step1_v11::^Systems::HemeOnc::Hematology
markdown: false

### Text
<div>
  Binding of <b>ADP</b> to the P2Y<sub>12</sub> receptor promotes
  optimal <u>exposure</u> of the <b>{{c1::GPIIb/IIIa}} receptor</b>
  on platelets
</div>

### Extra
<div>
  - induces conformational change of the receptor to increase
  affinity for fibrinogen
</div>
<div>
  - upregulates more GpIIb//IIIa receptors to the cell surface
</div>
<div>
  - this is the basis for P2Y12 inhibitors (ticlopidine,
  clopidogrel)
</div>
<div><img src="paste-47145856008193%20(1).jpg"></div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid
<img src="tmp4eLODm.png">

### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/heme-onc/hemostasis/acquire?ref=anki">
  <img src="_OME_AnkiFlashcards_Lesson_3.png"></a>
</div>

### Additional Resources


### One by one

